An inexpensive electrosynthetic strategy to produce 2,5-furandicarboxylic acid (FDCA) from biomass-derived furfural and CO2, enabling large-scale production of polyethylene furanoate (PEF), a greener replacement for PET in food packaging applications.
This solution offers a novel, cost-effective electrosynthetic pathway for producing 2,5-furandicarboxylic acid (FDCA), a critical building block for polyethylene furanoate (PEF), a bio-based alternative to petroleum-derived PET. FDCA is currently the primary bottleneck for large-scale PEF production. The approach leverages an inexpensive electrocatalytic bromine-mediated carboxylation strategy that converts industrially produced furfural (a lignocellulose-derived compound already available at 0.4 million tons per year) and CO2 into FDCA under ambient conditions.
PEF offers significant advantages over PET, including a tenfold improvement in oxygen permeability, making it highly attractive for food packaging applications where barrier performance is critical. By bypassing the conventional route that relies on the oxidation of 5-hydroxymethylfurfural (HMF), which faces economic and scalability challenges, this technology unlocks a more practical and sustainable supply chain for next-generation biopolymer packaging.
The technology has been validated at laboratory scale, with published results confirming near-quantitative conversion of furfural to 2-furoic acid and over 70% overall yield to FDCA under ambient conditions. Future efforts are directed toward process optimization, including catalyst development, applied potential tuning, and temperature variation to achieve industrial-relevant current density. Additional work focuses on designing silver alloy electrocatalysts to improve debromocarboxylation yields and integrating both reaction steps into a scaled-up flow cell. The technology is currently at an early-to-mid stage of development, with clear pathways toward pilot-scale demonstration and commercial deployment.
The University of Cincinnati is a comprehensive public research university with an applied, urban-serving character and a significant clinical enterprise. Industry engages through one of the nation's largest cooperative education programs, placing students year-round with corporate R&D and operations teams and creating an on-ramp to sponsored research. An innovation district near campus hosts co-located corporate labs, startup space, and shared prototyping facilities, while the university's integration with a major hospital system enables clinical studies and translation. Research is supported by competitive federal funding from agencies such as NIH and NSF, along with state and industry partnerships. A dedicated technology transfer office manages IP, licensing, corporate agreements, and startup formation, providing flexible models for collaboration.